Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-08-19 Sale |
2024-08-20 4:27 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
2,705 | $45.12 | $122,054 | 132,106 (Direct) |
View |
| 2024-06-11 Sale |
2024-06-11 7:34 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,823 | $31.34 | $57,133 | 134,811 (Direct) |
View |
| 2024-05-16 Sale |
2024-05-17 9:03 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
2,774 | $28.27 | $78,420 | 136,634 (Direct) |
View |
| 2024-03-08 Sale |
2024-03-13 06:04 am |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
109,601 | $26.11 | $2,861,373 | 169,542 (Direct) |
View |
| 2024-03-07 Sale |
2024-03-11 9:50 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
2,434 | $25.85 | $62,919 | 141,184 (Direct) |
View |
| 2024-02-29 Sale |
2024-03-01 9:37 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $28.46 | $811,865 | 167,878 (Direct) |
View |
| 2024-01-26 Sale |
2024-01-26 7:48 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $24.53 | $490,510 | 172,146 (Direct) |
View |
| 2024-01-02 Sale |
2024-01-04 9:47 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
31,900 | $16.59 | $529,194 | 242,683 (Direct) |
View |
| 2023-12-11 Sale |
2023-12-12 5:34 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,245 | $10.72 | $13,346 | 155,518 (Direct) |
View |
| 2023-09-18 Sale |
2023-09-20 4:49 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,261 | $9.41 | $11,866 | 60,605 (Direct) |
View |
| 2023-09-12 Sale |
2023-09-13 7:53 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
1,266 | $10.41 | $13,179 | 61,866 (Direct) |
View |
| 2023-06-12 Sale |
2023-06-14 6:40 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
2,259 | $12.68 | $28,649 | 63,132 (Direct) |
View |
| 2023-03-13 Sale |
2023-03-15 5:50 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
2,209 | $13.18 | $29,116 | 65,391 (Direct) |
View |
| 2023-01-18 Sale |
2023-01-23 08:27 am |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
10,000 | $14.03 | $140,300 | 136,128 (Direct) |
View |
| 2023-01-09 Sale |
2023-01-11 4:56 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
30,150 | $11.57 | $348,836 | 67,600 (Direct) |
View |
| 2022-12-12 Sale |
2022-12-13 5:05 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
472 | $10.87 | $5,131 | 160,750 (Direct) |
View |
| 2022-09-20 Sale |
2022-09-21 4:08 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
1,246 | $13.7 | $17,070 | 58,222 (Direct) |
View |
| 2022-09-15 Sale |
2022-09-15 5:27 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
494 | $14.05 | $6,941 | 59,468 (Direct) |
View |
| 2022-06-14 Sale |
2022-06-15 8:04 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
504 | $4.95 | $2,495 | 59,962 (Direct) |
View |
| 2022-03-11 Sale |
2022-03-14 5:09 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
481 | $8.73 | $4,199 | 60,466 (Direct) |
View |
| 2021-09-20 Sale |
2021-09-22 8:02 pm |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
1,274 | $15.9 | $20,252 | 35,636 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-07-11 Option Award |
2024-04-04 9:06 pm |
N/A 2033-07-10 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
35,000 | $0 | 35,000 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-13 06:04 am |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
107,825 | $0 | 169,542 (Direct) |
View |
| 2024-03-08 Exercise |
2024-03-13 06:04 am |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
107,825 | $5.54 | 169,542 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $0 | 167,878 (Direct) |
View |
| 2024-02-29 Exercise |
2024-03-01 9:37 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
28,528 | $0.73 | 167,878 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-26 7:48 pm |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $0 | 172,146 (Direct) |
View |
| 2024-01-26 Exercise |
2024-01-26 7:48 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $0.73 | 172,146 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:47 pm |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $0 | 242,683 (Direct) |
View |
| 2024-01-03 Exercise |
2024-01-04 9:47 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
20,000 | $0.73 | 242,683 (Direct) |
View |
| 2023-11-15 Option Award |
2023-11-16 4:34 pm |
N/A 2033-11-14 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan Chief Business Officer |
133,603 | $0 | 194,208 (Direct) |
View |
| 2023-01-18 Exercise |
2023-01-23 08:27 am |
N/A 2029-02-25 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
10,000 | $0 | 136,128 (Direct) |
View |
| 2023-01-18 Exercise |
2023-01-23 08:27 am |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
10,000 | $0.73 | 136,128 (Direct) |
View |
| 2022-12-09 Option Award |
2022-12-13 5:05 pm |
N/A 2032-12-08 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
103,000 | $0 | 160,750 (Direct) |
View |
| 2022-07-05 Option Award |
2022-07-06 6:21 pm |
N/A 2030-07-30 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
21,666 | $0 | 21,666 (Direct) |
View |
| 2021-12-10 Option Award |
2021-12-14 4:22 pm |
N/A 2031-12-09 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
63,278 | $0 | 98,914 (Direct) |
View |
| 2021-07-10 Option Award |
2021-07-13 4:22 pm |
N/A 2031-07-09 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
25,000 | $0 | 25,000 (Direct) |
View |
| 2020-09-16 Option Award |
2020-09-18 5:11 pm |
N/A 2030-09-15 |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
69,799 | $0 | 89,697 (Direct) |
View |
Ownership |
2020-09-16 8:45 pm |
N/A N/A |
Dyne Therapeutics Inc. | DYN | McNeill Jonathan See Remarks |
0 | $0 | 196,894 (Direct) |
View |